C-J Advisory’s AbbVie ABBV Stock Holding History

C-J Advisory’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-200	Closed	-$15K	–	41
2019 Q3	$15K	Hold	200	–	–	0.01%	116
2019 Q2	$15K	Hold	200	–	–	0.01%	112
2019 Q1	$16K	Buy	+200	New	+$16.4K	0.01%	123

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

C-J Advisory's ABBV Position: Q4 2019 in Review

C-J Advisory sold out of AbbVie (ABBV) in Q4 2019, closing a stake of 200 shares — an estimated $15K sold.

C-J Advisory first reported a position in ABBV in Q1 2019 and held it in 3 quarters. The position peaked at $16K in Q1 2019. 2,243 funds tracked by Wall St. Rank hold ABBV as of Q4 2019.

C-J Advisory reported no remaining AbbVie position as of Q4 2019 after selling out during the quarter.
C-J Advisory sold 200 AbbVie shares in Q4 2019, an estimated $15K.
C-J Advisory first reported a position in AbbVie in Q1 2019 and held it in 3 quarters.
C-J Advisory's AbbVie position peaked at $16K in Q1 2019.
2,243 funds tracked by Wall St. Rank held AbbVie as of Q4 2019.

Based on C-J Advisory's 13F filing for Q4 2019, filed 10 Feb 2020.